TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Concerned Partner Drinking Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concerned Partner Drinks per Episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Service Member help-seeking
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Left atrial remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in left atrial strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in left atrial systolic force
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptoms of pelvic congestion syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants achieving ACR20 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of radiation-related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Patient acceptability of ABM: Client Satisfaction Questionnaire (CSQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient acceptability of ABM: System Usability Scale (SUS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of participants achieving HiSCR50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with serum TBi ≥ 2 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peri-operative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of coronary flow reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Need for Whole Body Computed Tomography
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: SGLT-2 inhibitors related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: AUC-MAP < 65 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: changes in performance to obtain a reward
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: degree of chronic pain reduction
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Predictive diagnostic of NEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose - extent correlation coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posas score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination clearance rate (CL) of tranexamic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interventricular clearance rate (Q) of tranexamic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central ventricular volume (Vc) of tranexamic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral ventricular volume (Vp) of tranexamic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of ROP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gestational age at which treatment-requiring ROP develops
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Birthweight at which treatment-requiring ROP develops
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF-haemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in self-reported pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in type, dose and frequency of pain medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Achilles Tendon Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in hemiplegic arm movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of nasogastric tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of clinically bothersome radiation dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: knee joint space
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suprahyoid muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximum measurable tracer activity on 68Ga-Pentixafor PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Performance on a Cued Response Reaction Time Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mood Score 1
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mood Score 2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Degree of uptake of [68Ga]CBP8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the DASH index score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Complete control of vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in compensatory trunk dislocation at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in smoothness movement at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in elbow angle at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of motor block of the upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence rate of Venous Thromboembolism (VTE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Ciprofol EC50 (mg/Kg) for loss of consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid use in first 12 postoperative hours
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from baseline vaccination intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Body Awareness Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Nordic Musculoskeletal Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Chronic Obstructive Pulmonary Disease Assessment Test (CAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cough With Sputum Symptoms Assessment Questionnaire (CSSAQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Women's parenting stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of alterations in brain structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: nocturnal enuresis improvement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response to ParentText messages
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall completion rate of ParentText Content
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change over time in Child Maltreatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Quality of Life Inventory (PedsQL) area under the curve
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quick motor function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-month Modified Rankin Score (mRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutrophil count difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Functional mobility improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Success rate of the Digitrack use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in WOMAC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EULAR response after 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of PLX038 in primary CNS tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Articulation and intelligibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Receptive vocabulary skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Expressive vocabulary skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Receptive and expressive early language skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients lean mass as a percentage of body mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Body max index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Disordered eating behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Psychological impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: onset of spinal anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2000m Row Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Weekly Average of Daily Leg Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain level on the Numeric Rating Scale (NRS, 0-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of delirium within 3 days after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repair success rate of meniscal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Post Traumatic Stress Disorder (PTSD) symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUC of doravirine in pregnant women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of doravirine in pregnant women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmin of doravirine in pregnant women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CL/F of doravirine in pregnant women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in NT-pro-BNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Slope of mPA/CO after BPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent Engaged in Alcohol Use Disorder (AUD) Treatment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Number of Participants with End Stage Renal Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Participants with Adverse cardiovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with all cause death
Endpoint domain: Mortality/survival
Primary endpoint: Number of mature (MII) oocytes retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of Participants achieving and maintaining serum uric acid < 6 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: High Luminance High Contrast (HLHC) Binocular logMAR Visual Acuities at distance 4m
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High Luminance High Contrast (HLHC) Binocular logMAR Visual Acuities at intermediate distance 64cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High Luminance High Contrast (HLHC) Binocular logMAR Visual Acuities at near distance 40cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Achieving 2,000 Step/Day Increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in left ventricular volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in Heart Failure Class
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mammogram completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: surface EMG of masseter muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Periimplant bone level change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity of cirrhotic decompensated events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality of cirrhosis
Endpoint domain: Mortality/survival
Primary endpoint: Ability to Adapt
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time of OFF state of therapy during daily activity hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Wearing Off and ON-OFF phenomena
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of freezing of gait episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in the number of combustible cigarettes per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central physiological adaptations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral physiological adaptations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perioperative transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in average 24 hour systolic ambulatory blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of device- and treatment-related adverse and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients benefiting from pre-hospital transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increasing number of steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants presenting Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: decreasing blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Evolution of GSM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of Bioflx crown in primary molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of stainless steel molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation retention and completion of treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Patient engagement and program adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness in reducing meth use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of TEAEs, SAEs and DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of Adrenal incidentalomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Length of stay at the intensive care unit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Length of stay in the hospital by the modified Post-Anesthesia Discharge Scoring System (PADSS)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of re-interventions and number of participants with (serious) adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of MMS formulations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of Cryopreserved ovarian tissue transplantation
Endpoint domain: Adverse events/effects
Primary endpoint: Sense of community of the residents
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Managers' perception of the residents' sense of community
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Number of participants with abnormal safety laboratory parameters, vital signs and ECGs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genetic etiology for Recurrent Pregnancy Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: change in cognitive interference
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change in subjective stress perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 24hr glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Dietary Phe/Protein Consumption at Week 26
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Luminal loss at 13 months post procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients not requiring unplanned IBD related hospital visits or rescue therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Euploidy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Aneuploidy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Quantification of neutrophil extracellular traps (NETs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Trial Making Test (TMT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Surface electromyography (μV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: calcium oxalate supersaturation in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: calcium phosphate supersaturation in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: New cerebral infarcts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in high sensitivity CRP (hs-CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in interleukin-6 (IL-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete control rate of delayed nausea and vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of ultrasound exams
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gastric Residual Volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Efficacy of ticagrelor vs clopidogrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of ticagrelor vs clopidogrel
Endpoint domain: Adverse events/effects
Primary endpoint: Hemorrhagic infarction type 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: 8-Month Progression-Free Survival (PFS8)
Endpoint domain: Mortality/survival
Primary endpoint: postoperative sleep distribution
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Serum 15R-LXA4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence free survival time
Endpoint domain: Mortality/survival
Primary endpoint: Well-Being Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Monocular Photopic DCIVA at 66 cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocular Photopic BCDVA at 4 m
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: End expiratory lung impedance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: POSAS (patient and observer scar assessment score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of epidermal linear seal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of gastric antral vascular ectasia (GAVE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Camp positivity yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Experiencing Study Drug-related Toxicities
Endpoint domain: Adverse events/effects